Additional News on FOEDRC Member Michael Abramoff’s AI Device.

Dr. Abramoff’s software that is used to detect diabetic retinopathy, is marked the first medical device the FDA has approved to provide a screening decision without requiring a specialist to interpret the results.

Click here to read the full article.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close